Holen Sie sich die Stockscreener-App
1.5865
1.05%
0.0165
Schlusskurs vom Vortag:
$1.57
Offen:
$1.61
24-Stunden-Volumen:
2,893
Relative Volume:
0.03
Marktkapitalisierung:
$4.65M
Einnahmen:
$5.31M
Nettoeinkommen (Verlust:
$-2.90M
KGV:
-1.068
EPS:
-1.4855
Netto-Cashflow:
$-1.18M
1W Leistung:
-3.26%
1M Leistung:
-5.00%
6M Leistung:
-34.71%
1J Leistung:
-70.23%
1-Tages-Spanne:
$1.58
$1.61
1-Wochen-Bereich:
$1.54
$1.88
52-Wochen-Spanne:
$1.07
$6.10
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Firmenname
Bionexus Gene Lab Corp
Sektor
Branche
Telefon
1-307-241-6898
Adresse
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
2.29 | 2.99B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.72 | 401.38M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.98 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
4.81 | 314.59M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
47.85 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Aktie (BGLC) Neueste Nachrichten
11 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
Jook Yuen Low Net Worth (2026) - GuruFocus
Set Fui Chong Net Worth (2026) - GuruFocus
Fidelion Diagnostics Pte. Ltd. Net Worth (2026) - GuruFocus
Bin Abdul Hamid Muhammad Azrul Net Worth (2026) - GuruFocus
BioNexus Gene Lab Revenue Collapses 97% in Q2 as Major Customer Lost - Minichart
BioNexus Gene Lab Corp (BGLC) CEO reports 338,709-share award and 11.5% stake - Stock Titan
BioNexus Gene Lab Corp (BGLC) grants CEO 338,709 fully vested shares - Stock Titan
BioNexus Gene Lab Corp (BGLC) director receives 32,258-share fully vested award - Stock Titan
BioNexus Gene Lab Corp (BGLC) director receives 32,258-share equity award - Stock Titan
BioNexus Gene Lab Corp (BGLC) CFO receives 96,774-share equity award - Stock Titan
BioNexus Gene Lab Corp (BGLC) director granted 16,129-share fully vested stock award - Stock Titan
BioNexus Gene Lab Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nasdaq Firm Makes Historic Shift to Ethereum-Based Treasury - Yellow.com
BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. Ltd - Bitget
Fidelion Diagnostics reports 392,329 BioNexus Gene Lab Corp (NASDAQ: BGLC) shares - Stock Titan
BioNexus Gene Lab Corp (BGLC) Stock News Today - TradingKey
BioNexus Gene Lab (BGLC) Surges 8.3% to $1.43: Can Momentum Break the $1.50 Ceiling?Gap Down Bounce Plays - dars.gov.et
BioNexus Gene Lab (BGLC) director discloses 1,261 common shares in Form 3 - Stock Titan
BioNexus Gene Lab (BGLC) director files Form 3 with zero shares - Stock Titan
BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioNexus Says VitaGuard Blood Tests Could Cost Under $300 - Stock Titan
BGLC|BioNexus Gene Lab Corp|Price:1.370|Chg%:-0.140 - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.450|Chg%:-0.060 - TradingKey
BioNexus Gene Lab Corp Revenue Breakdown – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.510|Chg%:-0.050 - TradingKey
BioNexus Gene Lab Corp (BGLC) Cash Flow - TradingKey
TradingKey - TradingKey
BioNexus Gene Lab Corp (BGLC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.613|Chg%:-0.027 - TradingKey
BioNexus Gene Lab Corp (BGLC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioNexus Gene Lab Corp (BGLC) Edges Higher with Micro-Advance, Testing Key Resistance ZoneNews Sentiment - dars.gov.et
BioNexus Gene Lab (BGLC) Declines 2.35% – Support at $1.58 in FocusDollar Neutral Pair - Vinanet
12 Industrials Stocks Moving In Thursday's Pre-Market SessionEos Energy Enterprises, Inc.Right (NAS - Benzinga
Price to sales forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Enterprise value to revenue forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Number of shareholders of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Corp (BGLC) Edges Higher as Shares Test Key ResistanceMoney Flow Index - dars.gov.et
Enterprise value to EBITDA forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Company Profile & Introduction - Moomoo
Price to earnings forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Price to book forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
BioNexus Gene Lab Corp (BGLC) Slips 6.95% as Shares Test Key Support LevelsGEX Level - Město Břeclav
BioNexus Gene Lab Corp (BGLC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioNexus Gene Lab Corp (BGLC) Institutional Confidence - TradingKey
BioNexus Gene Lab Corp (BGLC) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Edges Higher as Shares Hold Above Key Support at $2.47Channel Breakout - newsline.com
Finanzdaten der Bionexus Gene Lab Corp-Aktie (BGLC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):